What's in Guangzhou Gloria Biosciences Co., Ltd.'s pipeline?

Guangzhou Gloria Biosciences Co., Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Guangzhou Gloria Biosciences Co., Ltd.'s portfolio?

Top competitors by shared drug class: ADvantage Therapeutics, AJU Pharm Co., Ltd., AO GENERIUM, Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/guangzhou-gloria-biosciences-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Guangzhou Gloria Biosciences Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Guangzhou Gloria Biosciences Co., Ltd. pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Chemotherapy of Investigator's choice	Chemotherapy of Investigator's choice	phase 3			Oncology
Placebo+G-CSF	Placebo+G-CSF	phase 3		G-CSF receptor	Oncology
Motixafortide+G-CSF	Motixafortide+G-CSF	phase 3	CXCR4 antagonist	CXCR4	Oncology
GLS-010	GLS-010	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Oncology · 3
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Guangzhou Gloria Biosciences Co., Ltd.:

Cite this brief

Drug Landscape (2026). Guangzhou Gloria Biosciences Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/guangzhou-gloria-biosciences-co-ltd. Accessed 2026-05-17.